Search the Newsreel

Avalyn Pharma (NASDAQ:AVLN) Cut to Sell at Wall Street Zen

Wall Street Zen has downgraded Avalyn Pharma (NASDAQ:AVLN) from a "hold" to a "sell" rating, despite the overall analyst sentiment being a "Moderate Buy" with a $60 average price target. Other firms like Jefferies, Guggenheim, and Evercore have issued "buy" or "outperform" ratings, while …

Cavalier Resources Reaches AU$26m Market Cap Benefiting Insider Stock Buying

Novo Holdings A/S (AVLN) discloses 8.8% beneficial stake in Avalyn Pharma

Novo Holdings A/S, an investment firm owned by the Novo Nordisk Foundation, has reported an 8.8% beneficial stake in Avalyn Pharma Inc. The firm holds 3,883,289 shares of Avalyn Pharma's voting common stock, with sole voting and dispositive power over these shares. The Novo …

Grupo Aval (AVAL) appoints new Internal Audit Manager after resignation

Q3 EPS Estimate for AvalonBay Communities Boosted by Analyst

Zacks Research increased its Q3 2026 EPS estimate for AvalonBay Communities (NYSE:AVB) to $2.80, with a full-year forecast of $11.32 per share. The REIT's stock rose 2.4% to $184.12, despite recently missing consensus EPS estimates but exceeding revenue expectations. Institutional investors hold a significant …

Sei Investments Co. Invests $849,000 in Avalo Therapeutics, Inc. $AVTX

Sei Investments Co. has acquired a new stake in Avalo Therapeutics (NASDAQ:AVTX), purchasing 56,854 shares valued at $849,000, which represents 0.19% of the company. Institutional investors now own 87.06% of AVTX, and analysts maintain a "Moderate Buy" rating with an average price target of …

Adavale Resources Shifts Share Registry as Parkes Gold Project Advances

Grupo Aval Acciones y Valores SA (AVAL) (Q2 2026) Earnings Call Highlights: Record Net Income ...

This article first appeared on GuruFocus. Release Date: August 13, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Attributable net income reached 577 billion Colombian pesos, up 17% YoY, the highest quarterly result …

Avalon Advanced Materials to Highlight Critical Minerals Strategy at Clean Energy Metals Investor Conference

AvalonBay, Equity Residential shareholders approve merger By Investing.com

Shareholders of AvalonBay Communities, Inc. (NYSE: AVB) and Equity Residential (NYSE: EQR) have overwhelmingly approved all proposals required to complete their merger of equals. The merger is anticipated to finalize on Monday, August 17, 2026, and the combined entity will be renamed Vivmark Residential, …

Grupo Aval (AVAL) makes June 30, 2026 quarterly results materials available

Grupo Aval Acciones y Valores S.A. (AVAL) has filed a Form 6-K announcing that materials for its quarterly consolidated results as of June 30, 2026, are now available online. These materials will be used for a results call scheduled for August 13, 2026. The …

Grupo Aval Acciones y Valores Q2 Earnings Call Highlights

This article first appeared on GuruFocus. Release Date: August 13, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Attributable net income reached 577 billion Colombian pesos, up 17% YoY, the highest quarterly result …

GRUPOAVAL: Net income up 17% YoY, ROAE at 12.7%, with 2026 ROAE guidance at 9.25% and stable asset quality

Grupo Aval (GRUPOAVAL) reported a 17% year-over-year increase in net income, reaching COP 577 billion, with a Return on Average Equity (ROAE) of 12.7%. The company provided 2026 guidance, projecting 10.5% loan growth and a ROAE of 9.25%. Asset quality and capital ratios are …

Earnings call transcript: Grupo Aval tops Q2 2026 revenue forecast as shares rise

Grupo Aval Acciones y Valores (AVAL) reported a strong second quarter in 2026, with attributed net income climbing 17% year-over-year to 577 billion pesos and revenue reaching $1.62 billion, significantly exceeding forecasts. The financial group benefited from a sharp rise in net interest income …

Grupo Aval Acciones y Valores S (AVAL) Q2 FY2025 earnings call transcript

Adavale Drilling Underpins Imminent London-Victoria Resource Upgrade

Handelsbanken Fonder AB Buys 32,137 Shares of AvalonBay Communities, Inc. $AVB

Handelsbanken Fonder AB increased its stake in AvalonBay Communities, Inc. (NYSE:AVB) by 41.1% during the second quarter, purchasing an additional 32,137 shares and bringing its total holdings to 110,350 shares valued at $20.82 million. Other institutional investors also adjusted their positions in the real …

GRUPOAVAL: Net income surged 71.6% QoQ, with strong loan growth, improved efficiency, and stable asset quality

Grupo Aval (GRUPOAVAL) reported a significant 71.6% quarter-over-quarter surge in attributable net income, alongside a 16.7% year-over-year increase, reaching a four-year high ROAE. The company demonstrated strong loan and deposit growth, improved efficiency, and maintained stable asset quality. These positive results were further supported …

Avalyn Pharma (NASDAQ:AVLN) Hits New 52-Week High Following Better-Than-Expected Earnings

Avalyn Pharma (NASDAQ:AVLN) shares reached a new 52-week high of $39.99 after reporting a quarterly loss of $0.98 per share, which surpassed analysts' expectations of a $1.03 loss. Analyst sentiment remains largely positive, with a consensus "Buy" rating and an average price target of …

AVAT Price Today: Avalanche Treasury Corporation Stock Price, Quote & Chart | MEXC

Form 8K AvalonBay Communities Inc For: 12 August By Investing.com

This article reports the filing of a Form 8K by AvalonBay Communities Inc. for August 12, as reported by Investing.com. It briefly mentions the company and its stock performance. The article primarily consists of financial market data, news headlines, and navigational elements from the …

AvalonBay Communities (NYSE: AVB) holders approve merger and 2.793‑for‑1 share exchange

AvalonBay Communities stockholders overwhelmingly approved the proposed merger of equals with Equity Residential, along with merger-related compensation and an adjournment proposal, at a special meeting on August 12, 2026. The merger is expected to close on August 17, 2026, with each AvalonBay share converting …

Equity Residential, AvalonBay shareholders approve merger (EQR:NYSE)

Shareholders of AvalonBay Communities (AVB) and Equity Residential (EQR) have approved all proposals for their pending merger of equals. The announcement was made after separate special meetings held by each multifamily REIT.

Equity Residential and AvalonBay Communities Announce Shareholder Approvals for Merger to Create Vivmark Residential

Equity Residential and AvalonBay Communities announced that shareholders of both companies have overwhelmingly approved the merger to create Vivmark Residential. The merger is expected to close on Monday, August 17, 2026, and the combined company's shares will trade under the ticker symbol "VMRK" on …

Avalo Therapeutics (AVTX) CSO Riley sells 2,655 shares at about $19.59

Avalo Therapeutics' Chief Strategy Officer, Jennifer Riley, sold 2,655 shares of common stock on August 11, 2026, at a weighted average price of $19.5903 per share. The transactions occurred within a price range of $19.54 to $19.65. Following this sale, Riley directly holds 37,041 …

Avalo Therapeutics (AVTX) CMO Mittie Doyle exercises options and sells 679 shares

Avalo Therapeutics (AVTX) Chief Medical Officer Mittie Doyle exercised options for 679 shares at $8.04 per share and subsequently sold the same number of shares at $20.00 per share on August 10, 2026. These transactions were executed under a pre-established Rule 10b5-1 trading plan. …

Grupo Aval Acciones y Valores SA Sponsored ADR Pfd Financial Disclosures & SEC Filings

This article provides a comprehensive list of financial disclosures and SEC filings for Grupo Aval Acciones y Valores S.A. (AVAL) from 2023 to 2026. It highlights key earnings reports, including details on net income, ROAE, loan growth, and capital ratios for various quarters. The …

Grupo Aval Acciones y Valores (NYSE:AVAL) Upgraded at JPMorgan Chase & Co.

JPMorgan Chase & Co. has upgraded Grupo Aval Acciones y Valores (NYSE:AVAL) from an "underweight" to a "neutral" rating, setting a $5.50 price target. This upgrade implies a potential 4.86% upside from the previous closing price, aligning with the overall neutral sentiment from analysts, …

Avalyn: Q2 Earnings Snapshot

Avalyn Pharma Inc. Q2 2026: Net loss $(28.9M), EPS $(0.98) — 10-Q Summary

Avalyn Pharma Inc. reported a wider net loss of $(28.9M) in Q2 2026, compared to $(20.2M) in Q2 2025, with basic and diluted net loss per share at $(0.98). The clinical-stage biotech company continues to invest in its development programs, including AP01, AP02, and …

Avalyn Pharma reports Q2 2026 net loss $28.9M; cash $413.5M, runway into 2029

Avalyn Pharma reported a Q2 2026 net loss of $28.9 million, ending the period with $413.5 million in cash, which is projected to fund operations into 2029. The company saw increased R&D and G&A expenses due to clinical activity and headcount. Key business highlights …

Form 8K Avalyn Pharma Inc. For: 12 August By Investing.com

This article reports that Avalyn Pharma Inc. has filed a Form 8K for August 12, as reported by Investing.com. The filing is brief and does not provide further details within the article content. It is categorized under stock market news.

Avalyn Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Avalyn Pharma Inc. announced its financial results for the second quarter ended June 30, 2026, and highlighted recent business achievements, including the completion of enrollment for its MIST global Phase 2b trial of AP01 with 398 patients. The company reported $413.5 million in cash, …